| Safety and Efficacy Study of MRE0094 to Treat Large, Single or Multiple, Chronic, Neuropathic, Diabetic Foot Ulcers (NCT00318214) | Pfizer | 2006-06-01 |
| A Study Of CP-195543 And Celecoxib Dual Therapy In Subjects With Rheumatoid Arthritis (NCT00424294) | Pfizer | 2006-06-01 |
| A Study In Patients With Non-Small Cell Lung Cancer Testing If Erlotinib Plus SU011248 (Sunitinib) Is Better Than Erlotinib Alone (NCT00265317) | Pfizer | 2006-06-01 |
| Zmax Compared to Augmentin in Sinusitis (NCT00367120) | Pfizer | 2006-06-01 |
| Study Evaluating Inotuzumab Ozogamicin [CMC-544] Administered In Combination With Rituximab In Subjects With Non-Hodgkin's Lymphoma (NHL) (NCT00299494) | Pfizer | 2006-05-04 |
| A Dose Finding Study Of A New Medication, PF-00337210 That Will Possibly Decrease Blood Supply To Tumors (NCT01105533) | Pfizer | 2006-05-01 |
| A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol. (NCT00443534) | Pfizer | 2006-05-01 |
| Evaluation Of Linezolid Pk Profile In Burns Patients (NCT00255996) | Pfizer | 2006-05-01 |
| Zyvox (Linezolid) Special Investigation For Vancomycin-Resistant Enterococci (VRE) (NCT01224626) | Pfizer | 2006-05-01 |
| Study Evaluating SKI-606 (Bosutinib) In Subjects With Breast Cancer (NCT00319254) | Pfizer | 2006-05-01 |
| Study of CP-751,871 in Combination With Docetaxel and Prednisone in Patients With Hormone Insensitive Prostate Cancer (HRPC) (NCT00313781) | Pfizer | 2006-05-01 |
| Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD). (NCT00285012) | Pfizer | 2006-05-01 |
| Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME I) (NCT00680160) | Pfizer | 2006-04-30 |
| A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer (NCT00585195) | Pfizer | 2006-04-19 |
| Voriconazole (Vfend) Drug Use Investigation (Regulatory Post Marketing Commitment Plan) (NCT01151085) | Pfizer | 2006-04-01 |
| Open Label Comparative Study Of De Novo Renal Allograft Recipients Receiving CSA + MMF + Corticosteroids Versus CSA + Rapamune + Corticosteroids (NCT01601821) | Pfizer | 2006-04-01 |
| A Single Dose Study to Evaluate the PK-PD Response and Safety of PHA-794428 in Children With Growth Hormone Deficiency (NCT00314938) | Pfizer | 2006-04-01 |
| Study Of The Efficacy And Safety Of SU-014813 In Patients With Metastatic Breast Cancer (NCT00322517) | Pfizer | 2006-04-01 |
| Study Comparing Effect On Carotid Atherosclerosis Following Conversion From Tacrolimus To Sirolimus Post-Transplant In Kidney Transplant Patients (NCT00311311) | Pfizer | 2006-04-01 |
| A Study of the Effectiveness of Sitaxsentan Sodium in Patients With Diastolic Heart Failure (NCT00303498) | Pfizer | 2006-03-27 |
| A Clinical Trial Assessing The Impact Of Inhaled Insulin On Glucose Control In Patients With Type 2 Diabetes Mellitus (NCT00282971) | Pfizer | 2006-03-06 |
| Voriconazole Versus Itraconazole In Primary Prophylaxis Of Invasive Fungal Infection (IFI) In Subjects With Allogeneic Hematopoietic Stem Cell Transplants (HSCT) (NCT00289991) | Pfizer | 2006-03-01 |
| A Phase II Study Looking at Moderate to Severe Osteoarthritis Knee Pain (NCT00394563) | Pfizer | 2006-03-01 |
| Study Evaluating the Safety, Tolerability, and Efficacy of Lecozotan SR in Outpatients With Alzheimer's Disease (NCT00277810) | Pfizer | 2006-03-01 |
| Non-Interventional Post Marketing Surveillance Study To Observe The Safety And Efficacy Of Vfend® IV (NCT01073618) | Pfizer | 2006-03-01 |
| Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery (NCT00306254) | Pfizer | 2006-03-01 |
| Safety Of VIRACEPT® 625mg Administered To HIV-Infected Women During Pregnancy (NCT00246610) | Pfizer | 2006-03-01 |
| [S,S]-Reboxetine Dose-Range Finding Trial (NCT00288652) | Pfizer | 2006-03-01 |
| A Three Day Trial of Azithromycin Plus Chloroquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria (NCT00282919) | Pfizer | 2006-03-01 |
| Non-Interventional Post Marketing Surveillance Study To Observe The Safety And Efficacy Of Vfend® Tablet In Korea (NCT01073631) | Pfizer | 2006-03-01 |
| Thorough QT Study of Nelfinavir (NCT00312182) | Pfizer | 2006-03-01 |
| Study Of AG-013736 In Patients With Refractory Metastatic Renal Cell Cancer (NCT00282048) | Pfizer | 2006-03-01 |
| Study of Different Doses of a Novel Treatment for Onychomycosis (NCT00679965) | Pfizer | 2006-02-28 |
| A Study in Asymptomatic HIV Infected Patients to Investigate Pharmacodynamics, Pharmacokinetics, Safety and Toleration of UK-453,061 (NCT00348673) | Pfizer | 2006-02-01 |
| An International Phase 2 Study Of SU011248 In Patients With Inoperable Liver Cancer (NCT00247676) | Pfizer | 2006-02-01 |
| Open Label Study Of SU011248 In Combination With Trastuzumab For Patients With Metastatic Breast Cancer (NCT00243503) | Pfizer | 2006-02-01 |
| 6-Month Safety And Efficacy Study Of TTP488 In Patients With Type 2 Diabetes And Persistent Albuminuria (NCT00287183) | Pfizer | 2006-02-01 |
| CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Non-Responder (Null And Partial Responder) Hepatitis C Virus (HCV) Genotype 1 Infected Subjects (NCT00277238) | Pfizer | 2006-02-01 |
| Efficacy and Safety of Varenicline in Smokers With Cardiovascular Disease Who Wish to Quit Smoking (NCT00282984) | Pfizer | 2006-02-01 |
| A Clinical Trial Assessing the Impact of Inhaled Insulin on Glucose Disposition (NCT00287066) | Pfizer | 2006-02-01 |
| A Trial To Evaluate Two Antibiotics For The Treatment Of Acute Exacerbation Of Chronic Bronchitis (AECB) (NCT00254566) | Pfizer | 2006-02-01 |
| Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias (NCT00261846) | Pfizer | 2006-01-18 |
| A Study To Assess The Efficacy And Safety Of Voriconazole In Chinese Patients With Serious Deep Tissue Fungal Infections (NCT00288197) | Pfizer | 2006-01-01 |
| Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists (NCT00293722) | Pfizer | 2006-01-01 |
| A Randomized Double Blind, Placebo Controlled Balanced 4-Way Crossover Study To Assess The Efficacy Of Single Oral Doses (NCT00273416) | Pfizer | 2006-01-01 |
| Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Dermatologists (NCT00293709) | Pfizer | 2006-01-01 |
| A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol (A5091031). (NCT00267280) | Pfizer | 2006-01-01 |
| Neoadjuvant Colorectal Cancer With Unresectable Liver Metastases (NCT00106054) | Pfizer | 2006-01-01 |
| Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer (NCT00246571) | Pfizer | 2006-01-01 |
| Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures. (NCT00319501) | Pfizer | 2006-01-01 |
| Beta Cell Function Tests Over Time In Patients With T2dm Randomized To Metformin Or Rosiglitazone (NCT00282945) | Pfizer | 2006-01-01 |
| A Study Of Different Doses Of TBC3711 In Patients With Uncontrolled High Blood Pressure Already Taking Medications For High Blood Pressure. (NCT00272961) | Pfizer | 2006-01-01 |
| An International Phase 2 Study Of SU011248 In Patients With Advanced / Metastatic Gastric Cancer Failing Chemotherapy (NCT00226811) | Pfizer | 2006-01-01 |
| Study With AG-013736 Combined With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal Cancer (NCT00460603) | Pfizer | 2006-01-01 |
| A Clinical Trial Comparing Torcetrapib/Atorvastatin to Ezetimibe/Simvastatin In Subjects With A Cholesterol Disorder. (NCT00267267) | Pfizer | 2006-01-01 |
| A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol. (NCT00267254) | Pfizer | 2006-01-01 |
| Evaluation Of A Novel Methodology In The Assessment Of Urethral Function Using SS-RBX. (NCT00141128) | Pfizer | 2005-12-01 |
| Investigation of Tolterodine, Pregabalin and a Tolterodine - Pregabalin Combination for the Treatment of Overactive Bladder (NCT00746681) | Pfizer | 2005-12-01 |
| Study of SU011248 in Patients With Advanced Kidney Cancer (NCT00254540) | Pfizer | 2005-12-01 |
| Extension Study Of Stage 1 Subjects Of Study A3921009 For The Prevention Of Acute Rejection In Kidney Transplant Patient (NCT00263328) | Pfizer | 2005-12-01 |
| The Aim is to Estimate the Total Amount of Insulin-producing Cells in the Pancreas by MRI. (NCT00280085) | Pfizer | 2005-12-01 |
| Safety and Efficacy Study of MRE0094 to Treat Chronic, Neuropathic, Diabetic Foot Ulcers (NCT00312364) | Pfizer | 2005-12-01 |
| Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumor (NCT00454649) | Pfizer | 2005-12-01 |
| Sunitinib Malate Schedule 4/2 vs. Sunitinib Malate Continuous Dosing As First-Line Therapy For Metastatic Renal Cell Cancer (RCC) (NCT00267748) | Pfizer | 2005-12-01 |
| A Research Study to Compare the Treatments of a Combination of Elzasonan With Zoloft, to Zoloft Alone, or Placebo in People With Major Depressive Disorder (MDD) (NCT00275197) | Pfizer | 2005-12-01 |
| Randomized Ph 2 Trial Of Paclitaxel/Carboplatin /Bevacizumab + PF-3512676 And P/C/B Alone In Advanced Nonsquamous NSCLC (NCT00313768) | Pfizer | 2005-12-01 |
| MEK Inhibitor PD-325901 To Treat Advanced Non-Small Cell Lung Cancer (NCT00174369) | Pfizer | 2005-11-01 |
| Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLC (NCT00254904) | Pfizer | 2005-11-01 |
| A Study To Measure The Level Of Drug In Nasal Tissue And Blood After Taking A Single 2g Dose Or 500mg Tablets For Up To (NCT00232154) | Pfizer | 2005-11-01 |
| Study Of SU011248 In Combination With Paclitaxel/Carboplatin In Patients With Advanced Solid Tumors (NCT00511849) | Pfizer | 2005-11-01 |
| Phase 2 Study of the Safety and Efficacy of UK-500,001 in Adult Patients With COPD (NCT00263874) | Pfizer | 2005-11-01 |
| US Inhaled Insulin Dose Titration Study (NCT00246623) | Pfizer | 2005-11-01 |
| Safety and Efficacy Study of Subjects With Onychomycosis of the Great Toenail (NCT00679523) | Pfizer | 2005-11-01 |
| Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer (NCT00254891) | Pfizer | 2005-11-01 |
| Sequencing Of Endocrine Therapy In Post-Menopausal Women With Early Breast Cancer (FAST) (NCT01050634) | Pfizer | 2005-11-01 |
| A 5-Week Trial Of PD 0332334 And Alprazolam Extended Release Compared To Placebo In Patients With Generalized Anxiety Disorder (NCT00921063) | Pfizer | 2005-11-01 |
| A Study To Estimate The Effect Of Omeprazole On The Pharmacokinetics Of Nelfinavir In Healthy Subjects (NCT00251030) | Pfizer | 2005-11-01 |
| Study To Evaluate The Safety, Pharmacokinetics, And Pharmacodynamics Of PF-00299804 In Patients With Advanced Solid Tumors (NCT00225121) | Pfizer | 2005-10-11 |
| An Open Label Study To Evaluate The Safety and Kinetics of Nelfinavir in Subjects With HIV and Hepatitis C (NCT00141284) | Pfizer | 2005-10-01 |
| The Dose Response of Prednisone on Biochemical and Clinical Makers in Adult Healthy Volunteers (NCT02767089) | Pfizer | 2005-10-01 |
| Efficacy and Safety Study of Binodenoson in Assessing Cardiac Ischemia (NCT00944970) | Pfizer | 2005-10-01 |
| Randomized Study Of Exercise And Vitamin D In Frail Elderly Subjects (NCT00249704) | Pfizer | 2005-10-01 |
| Study Of SU011248 In Combination With Docetaxel (Taxotere) And Prednisone In Patients With Prostate Cancer (NCT00137436) | Pfizer | 2005-10-01 |
| A Safety and Tolerability Evaluation of Two 10-Week Dose Regimens of Orally-Administered PF-04494700 in Alzheimer's Patients (NCT00141661) | Pfizer | 2005-10-01 |
| Clinical Study Of Pegaptanib Sodium (EYE001) For Wet-Type Age-Related Macular Degeneration (NCT00239928) | Pfizer | 2005-09-01 |
| Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Postmenopausal Women (NCT00242710) | Pfizer | 2005-09-01 |
| CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Relapsed Hepatitis C Virus (HCV) Subjects (NCT00142103) | Pfizer | 2005-09-01 |
| A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer (NCT00113516) | Pfizer | 2005-09-01 |
| A Study To Investigate The Safety And Efficacy Properties Of PF-00547659 In Patients With Active Ulcerative Colitis (NCT00928681) | Pfizer | 2005-09-01 |
| Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension (NCT00139698) | Pfizer | 2005-09-01 |
| Study Of Sunitinib Plus FOLFOX In Patients With Solid Tumors (NCT00599924) | Pfizer | 2005-09-01 |
| Study Of SU011248 Administered On A Continuous Daily Dosing Schedule In Patients With Gastrointestinal Stromal Tumor (NCT00137449) | Pfizer | 2005-09-01 |
| Study Of SU011248 In Combination With Paclitaxel In Patients With Metastatic Breast Cancer (NCT00174434) | Pfizer | 2005-09-01 |
| Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections (NCT00108433) | Pfizer | 2005-09-01 |
| Azithromycin Microspheres in Patients With Low Risk Community Acquired Pneumonia (NCT00140023) | Pfizer | 2005-09-01 |
| A Multi-Center Trial To Evaluate The Safety And Efficacy Of Pegaptanib Sodium(Macugen) Injected Into The Eye Every 6 Weeks For Up To 2 Years For Macular Swelling Associated With Diabetes, With An Open-Label Macugen Year Extension. (NCT00605280) | Pfizer | 2005-09-01 |
| Study Of Anti-IGF-IR CP-751,871 In Patients With Solid Tumors (NCT00474760) | Pfizer | 2005-08-01 |
| Somatropin Therapy In Children Born Preterm But Appropriate For Gestational Age (NCT00174460) | Pfizer | 2005-08-01 |
| AG-013736 In Combination With Gemcitabine Versus Gemcitabine Alone For Patients With Metastatic Pancreatic Cancer (NCT00219557) | Pfizer | 2005-07-05 |
| Voriconazole For Chronic Bronchopulmonary Aspergillosis (NCT00159822) | Pfizer | 2005-07-01 |